Natural Supplements and Remedies, Inc. – Trademark Portfolio
Entity Type: 03
Natural Supplements and Remedies, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include URINOZINC. The owner is based in Miami, FL.
4051 Northwest 26th Street
Miami, FL 33142
Showing of trademarks Trademarks
Trademark Classifications
Natural Supplements and Remedies, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Natural Supplements and Remedies, Inc. have?
Natural Supplements and Remedies, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 cancelled.
What trademark classes does Natural Supplements and Remedies, Inc. file in?
Natural Supplements and Remedies, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Natural Supplements and Remedies, Inc.'s most well-known trademarks?
Natural Supplements and Remedies, Inc.'s registered trademark portfolio includes well-known marks such as URINOZINC. These are among 1 currently registered trademark in the portfolio.
What is Natural Supplements and Remedies, Inc.'s trademark registration success rate?
Natural Supplements and Remedies, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.